Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2013 / Feb / Analysis of Synthetic Oligomers and Polymers
Pharma and Biopharma Pharma and Biopharma Materials Science Sponsored

Analysis of Synthetic Oligomers and Polymers

New roles and applications in the areas of science & technology are continuously being found for synthetic polymers. As the applications of synthetic polymers increase, there is a need for methods to accurately, precisely characterize these materials.

02/21/2013 1 min read

Sponsored By

Share

The utility of size exclusion chromatography (SEC or gel permeation chromatography, GPC) for synthesis monitoring and oligomeric analysis makes it an invaluable tool for characterizing synthetic polymeric material for use in medicine, as these materials require thorough characterization. The synthesis of two PEGylated synthetic polymers intended for use in medical applications was monitored and the oligomeric content was analyzed on an EcoSEC GPC System equipped with a column bank consisting of two 6.0 mm ID × 15 cm, 3 μm TSKgel® SuperH3000 columns. The synthesis process was analyzed by comparing the SECchromatograms of the two PEGylated polymers with that of one of the starting materials. From this comparison it was concluded that starting material remained in one of the PEGylated samples, PEG-A, and was absent in the other PEGylated sample, PEG-B (Figure 1). The SEC chromatograms of the PEGylated polymers also provided indication of differences in the molar mass distribution between the two PEGylated samples. Additionally, based on the peak-average molar masses Mp the oligomeric content of the two PEGylated polymers were shown to differ, with PEG-A containing mainly oligomeric species and PEG-B containing both low- and high-molar mass species.

Graphic of  Synthesis monitoring of pegylated polymersFig 1: Synthesis monitoring of pegylated polymers. Elution profile of PEG-A (red), PEG-B (blue), and starting material c (green) monitored by ri detection at 0.3 Ml/min in THF at 35°c

Isocyanates are both highly reactive and highly toxic low molar mass chemicals. One comon technique used to take advantage of isocyanate reactivity while eliminating safety concerns is to synthesize polyurethane prepolymers for use in subsequent polymerizations. The physical properties of the resultant polymer are influenced to a large degree by the size of the polyol chains in the prepolymer. Harder polymers are formed with larger polyol chains and softer polymers are formed with smaller polyol chains. The molar mass and molar mass averages of an isocyanate modified polyurethane prepolymer (IMPP) with residual dimethyl sulfoxide (DMSO) were measured with an EcoSEC GPC System with a refractive index detector using a column bank consisting of two TSKgel SuperH3000 columns and tetrahydrofuran (THF) as mobile phase. The low dead volume of the EcoSEC GPC System combined with the use of semi-micro GPC columns allowed for an efficient separation and characterization of the prepolymer sample in less than hour. The molar mass averages and polydispersity index of the IMPP sample was determined using a polystyrene relative calibration curve. The chromatogram of the IMPP displayed twelve distinctive peaks. Peaks 1 through 5 were determined to be the urethane prepolymer component of the IMPP. The sample was analyzed at two different chromatographic flow rates, 0.3 and 0.6 mL/min. The flow rate of 0.6 mL/min (Figure 2) compared to that of 0.3 mL/min resulted in a decrease in analysis time from 45 minutes to 22 minutes.

Graphic of GPC elution profileFig 2: GPC elution profile of impp sample. Monitored by ri detection at 0.6 Ml/min in THF at 35 °c.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

Loading the Molecular Dice
Pharma and Biopharma
Loading the Molecular Dice

December 12, 2024

2 min read

How a framework for controlling molecular reactions at the atomic scale has potential implications for nanotechnology, pharmaceutical synthesis, and clean energy research

CD-MS: To Megadalton and Beyond
Pharma and Biopharma
CD-MS: To Megadalton and Beyond

October 1, 2024

10 min read

Charge-detection mass spectrometry (CD-MS) has extended the range of MS to gigadalton-sized viruses and polymers; and with a commercial instrument in development and exciting new applications in complex protein mixtures, maturity beckons

New NMR Technique Enables Direct Detection of Molecular Chirality
Pharma and Biopharma
New NMR Technique Enables Direct Detection of Molecular Chirality

October 1, 2024

1 min read

Researchers develop an NMR method to distinguish between enantiomers without the need for chiral agents

Mass Spec Imaging Meets Proteomics
Pharma and Biopharma
Mass Spec Imaging Meets Proteomics

October 2, 2024

2 min read

Researchers combine tissue imaging with proteomics to shed light on the neurotoxic effects associated with HIV medication Efavirenz treatment

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.